InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2021-07-30 00:00:00 ET · period of report 2021-07-28 · accession 0000899243-21-030878 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-07-30 2021-07-28 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $11.50 +110.6K 8.30M +1% +$1.27M
DMI 2021-07-30 2021-07-28 HIMS Dudum Andrew CEO, Dir, 10% F - Tax — -81.1K 2.87M -3% —
DMI 2021-07-30 2021-07-28 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -110.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-07-28 M A 16,028 $11.50 2,882,258 I Held by Trustee of the AD GRAT dated 8/31/20 — —
2 Common Class A Common Stock 2021-07-28 F D 69,329 — 8,232,404 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — — (F1) The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
3 Common Class A Common Stock 2021-07-28 F D 11,749 — 2,870,509 I Held by Trustee of the AD GRAT dated 8/31/20 — — (F1) The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
4 Common Class A Common Stock 2021-07-28 M A 94,582 $11.50 8,301,733 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — —
5 Derivative Warrant (right to buy) 2021-07-28 M D 94,582 $0.00 0 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 $11.50 · 2021-01-20 to 2026-01-20 94,582 Class A Common Stock
6 Derivative Warrant (right to buy) 2021-07-28 M D 16,028 $0.00 0 I Held by Trustee of the AD GRAT dated 8/31/20 $11.50 · 2021-01-20 to 2026-01-20 16,028 Class A Common Stock